Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 15, 2021 08:30 ET | Source: BioCorRx, Inc.

BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders

ANAHEIM, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
November 16, 2020 08:30 ET | Source: BioCorRx, Inc.

BioCorRx Provides Business Update for the Third Quarter of 2020; BioCorRx Subsidiary, BioCorRx Pharmaceuticals Inc. Progressing with Pivotal Nonclinical BICX102 Study

Announces Promotion of Lourdes Felix to CEO; Brady Granier to Serve as President ANAHEIM, CA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ BioCorRx Inc. (OTCQB: BICX) (the “Company”), a...
March 31, 2020 08:30 ET | Source: BioCorRx, Inc.

BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic

ANAHEIM, CA, March 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
October 07, 2019 08:30 ET | Source: BioCorRx, Inc.

BioCorRx Announces Capital Restructuring and Provides Business Update

ANAHEIM, CA, Oct. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
November 14, 2018 08:00 ET | Source: BioCorRx, Inc.

BioCorRx Provides Business Update for the Third Quarter of 2018

ANAHEIM, CA, Nov. 14, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – BioCorRx, Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
May 21, 2018 07:30 ET | Source: BioCorRx, Inc.

BioCorRx Provides Business Update for the First Quarter of 2018

ANAHEIM, CA, May 21, 2018 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use disorders, today provided...
April 10, 2018 07:30 ET | Source: BioCorRx, Inc.

BioCorRx to Exhibit at ASAM 49th Annual Conference in San Diego, California

ANAHEIM, CA, April 10, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company), a developer and provider of advanced solution in the treatment of alcohol and opioid addition, today...
February 08, 2018 07:30 ET | Source: BioCorRx, Inc.

BioCorRx Extends Service Agreement with Dr. Balbir S. Brar as VP of Drug Development Following Pre-IND Meeting with the U.S. FDA

ANAHEIM, CA, Feb. 08, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
January 26, 2018 07:30 ET | Source: BioCorRx, Inc.

BioCorRx Completes Pre-IND Meeting with FDA; Reports Company to Move Forward with BICX102

ANAHEIM, CA , Jan. 26, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today...
December 14, 2017 11:23 ET | Source: BioCorRx, Inc.

BioCorRx Enters Agreement with National Institute on Alcohol Abuse and Alcoholism

ANAHEIM, CA, Dec. 14, 2017 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of alcohol and opioid addiction, today...

Next Page keyboard_arrow_right